TrialDrug design, development and therapy2025

Pharmacokinetics, Relative Bioavailability, and Safety of the SHR0302 Oral Solution and Tablets: A Single-Center, Randomized, Open-Label, Crossover (Two-Formulation, Two-Period) Phase I Trial in Healthy Chinese Volunteers.

Xin Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.